Compared to Estimates, ChargePoint (CHPT) Q4 Earnings: A Look at Key Metrics

Zacks
5 hours ago

For the quarter ended January 2025, ChargePoint Holdings, Inc. (CHPT) reported revenue of $101.89 million, down 12% over the same period last year. EPS came in at -$0.06, compared to -$0.13 in the year-ago quarter.

The reported revenue compares to the Zacks Consensus Estimate of $102.48 million, representing a surprise of -0.58%. The company delivered an EPS surprise of +25.00%, with the consensus EPS estimate being -$0.08.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how ChargePoint performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Networked charging systems: $52.62 million versus the four-analyst average estimate of $53.60 million.
  • Subscriptions: $38.27 million compared to the $36.90 million average estimate based on four analysts.
  • Other: $11 million compared to the $10.20 million average estimate based on four analysts.
View all Key Company Metrics for ChargePoint here>>>

Shares of ChargePoint have returned -35.8% over the past month versus the Zacks S&P 500 composite's -2.3% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

ChargePoint Holdings, Inc. (CHPT) : Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10